Promising Steps Toward Retinal Cell Transplants to Fight Blindness
TUESDAY, Jan. 19, 2021 -- A promising step toward using retinal cell transplants to treat blindness is reported in a new study. Adult retinal stem cells from deceased human donors survived when they were transplanted into the eyes of non-human... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 19, 2021 Category: General Medicine Source Type: news

Genome editing to treat human retinal degeneration
(Mary Ann Liebert, Inc./Genetic Engineering News) Gene editing therapies, including CRISPR-Cas systems, offer the potential to correct mutations causing inherited retinal degenerations, a leading cause of blindness. Technological advances in gene editing, continuing safety concerns, and strategies to overcome these challenges (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 19, 2021 Category: International Medicine & Public Health Source Type: news

Retinal stem cells from cadavers may help restore vision in blind, study finds
Retinal stem cells collected from human cadavers offer a potential treatment for blindness, according to the authors of an article published Thursday by Stem Cell Reports. (Source: Health News - UPI.com)
Source: Health News - UPI.com - January 14, 2021 Category: Consumer Health News Source Type: news

55 scientists funded to explore their research's commercial potential
(European Research Council) A new low-cost test for COVID19, how to share cultural expertise to solve conflicts, a way to help develop new medicines to treat blindness, further improvements to a clean energy producing technology - just some examples of how frontier researchers will use extra ERC funding to improve our lives. 55 researchers will receive ERC Proof of Concept grants to explore the commercial or societal potential of their work and to bring their work closer to the market. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - January 7, 2021 Category: International Medicine & Public Health Source Type: news

The United States Eye Injury Registry: past and future directions - Chen A, McGwin GJ, Justin GA, Woreta FA.
Worldwide, eye trauma is a significant burden and the leading cause of monocular blindness. An estimated 3.15 per 1000 population eye injuries are treated every year in emergency departments throughout the United States. Additionally, nearly one third of p... (Source: SafetyLit)
Source: SafetyLit - January 5, 2021 Category: International Medicine & Public Health Tags: Burns, Electricity, Explosions, Fire, Scalds Source Type: news

How Good is Photoscreening For Young Children ’ s Vision Problems?
This study showed that not only was smartphone photoscreening feasible, but was quite good at screening for potential vision problems. Smartphone photoscreening has the advantages of being more ubiquitously available and thus children in almost any location can be screened. A study of photoscreening using a handheld digital photoscreener in primary care offices validated the technology showing an overall referral rate of 10% to an ophthalmologist with suspected astigmatism, anisometropia and strabismus being the most common reasons. The overall positive predictive rate was 0.60. “…[O]ver 60% of children referr...
Source: PediatricEducation.org - January 4, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Thousands at risk of blindness set to benefit from a new eye drug
Brolucizumab, has now been approved by NHS chiefs for patients with wet age-related macular deterioration - a painless yet incurable eye disease that's the leading cause of blindness in over-55s. (Source: the Mail online | Health)
Source: the Mail online | Health - January 2, 2021 Category: Consumer Health News Source Type: news

Why Do We Dream? A New Theory on How It Protects Our Brains
When he was two years old, Ben stopped seeing out of his left eye. His mother took him to the doctor and soon discovered he had retinal cancer in both eyes. After chemotherapy and radiation failed, surgeons removed both his eyes. For Ben, vision was gone forever. But by the time he was seven years old, he had devised a technique for decoding the world around him: he clicked with his mouth and listened for the returning echoes. This method enabled Ben to determine the locations of open doorways, people, parked cars, garbage cans, and so on. He was echolocating: bouncing his sound waves off objects in the environment and cat...
Source: TIME: Science - December 29, 2020 Category: Science Authors: David Eagleman and Don Vaughn Tags: Uncategorized Source Type: news

'Liquid nose jobs' outlawed for B.C. naturopaths over concerns about blindness and skin death
Naturopaths in B.C. have been banned from performing liquid rhinoplasty, a procedure marketed as a quick and relatively painless alternative to surgery that nonetheless can cause serious complications. (Source: CBC | Health)
Source: CBC | Health - December 24, 2020 Category: Consumer Health News Tags: News/Canada/British Columbia Source Type: news

Reflecting Back and Imagining Forward
By Anis ChowdhurySYDNEY, Dec 24 2020 (IPS) What a challenging year 2020 has been! A year of living dangerously – “Tahun vivere pericoloso”- perhaps these words of late President Soekarno of Indonesia are the best description. Fortunately, I managed to remain sane, reading and writing op-eds (mostly about the pandemic, here, here). Anis ChowdhuryI began the year 2020 with an interview with New Age (Dhaka, 12 Feb.), headlined, “We need to Democratise Politics” where I highlighted the perils of growing inequality and how it could be a greater threat than the evolving pandemic for the human race...
Source: IPS Inter Press Service - Health - December 24, 2020 Category: International Medicine & Public Health Authors: Anis Chowdhury Tags: Climate Change Economy & Trade Environment Financial Crisis Global Headlines Health Humanitarian Emergencies Inequity Labour TerraViva United Nations Source Type: news

Roche ’s faricimab meets primary endpoint and shows strong durability across two global phase III studies for diabetic macular edema, a leading cause of blindness
Basel, 21 December 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced positive topline results from two identically designed global phase III studies, YOSEMITE and RHINE, evaluating its investigational bispecific antibody, faricimab, in people living with diabetic macular edema (DME). Both studies met their primary endpoint and showed that faricimab given every eight weeks and at personalised dosing intervals of up to 16 weeks demonstrated non-inferior visual acuity gains compared to aflibercept given every eight weeks. Faricimab was generally well-tolerated, with no new safety signals identified. The studies each h...
Source: Roche Media News - December 21, 2020 Category: Pharmaceuticals Source Type: news

Roche ’s faricimab meets primary endpoint and shows strong durability across two global phase III studies for diabetic macular edema, a leading cause of blindness
Basel, 21 December 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced positive topline results from two identically designed global phase III studies, YOSEMITE and RHINE, evaluating its investigational bispecific antibody, faricimab, in people living with diabetic macular edema (DME). Both studies met their primary endpoint and showed that faricimab given every eight weeks and at personalised dosing intervals of up to 16 weeks demonstrated non-inferior visual acuity gains compared to aflibercept given every eight weeks. Faricimab was generally well-tolerated, with no new safety signals identified. The studies each h...
Source: Roche Investor Update - December 21, 2020 Category: Pharmaceuticals Source Type: news

Thousands are risking blindness because they don't use their eye drops properly, warn experts
The concern follows recent reports that only half of the 480,000 sufferers of glaucoma - the most common eye condition in the UK - are given clear instructions for using their medication. (Source: the Mail online | Health)
Source: the Mail online | Health - December 19, 2020 Category: Consumer Health News Source Type: news

Penn vision researchers honored by End Blindness 2020
(University of Pennsylvania) The Outstanding Achievement Prize highlights the contributions of the School of Veterinary Medicine's Gustavo D. Aguirre and the Perelman School of Medicine's Jean Bennett and Albert M. Maguire toward a gene therapy for a form of blindness. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 15, 2020 Category: International Medicine & Public Health Source Type: news

Gene Therapy in One Eye Improves Vision in Both Eyes
It’s not clear why the patients with Leber hereditary optic neuropathy, a mitochondrial disorder that causes blindness, also experienced the modest benefits in their untreated eye. (Source: The Scientist)
Source: The Scientist - December 11, 2020 Category: Science Tags: News & Opinion Source Type: news

OHSU physician honored for co-invention of eye-imaging technology
(Oregon Health& Science University) Oregon Health& Science University researcher David Huang, M.D., is being honored by the Sanford and Susan Greenberg Prize to End Blindness for co-inventing an eye imaging technology that is widely used to diagnose and guide treatment for people with the leading causes of blindness. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - December 11, 2020 Category: International Medicine & Public Health Source Type: news

Shape perception via a high-channel-count neuroprosthesis in monkey visual cortex
Blindness affects 40 million people across the world. A neuroprosthesis could one day restore functional vision in the blind. We implanted a 1024-channel prosthesis in areas V1 and V4 of the visual cortex of monkeys and used electrical stimulation to elicit percepts of dots of light (called phosphenes) on hundreds of electrodes, the locations of which matched the receptive fields of the stimulated neurons. Activity in area V4 predicted phosphene percepts that were elicited in V1. We simultaneously stimulated multiple electrodes to impose visible patterns composed of a number of phosphenes. The monkeys immediately recognize...
Source: ScienceNOW - December 3, 2020 Category: Science Authors: Chen, X., Wang, F., Fernandez, E., Roelfsema, P. R. Tags: Neuroscience r-articles Source Type: news

Janssen Acquires Rights to Novel Gene Therapy, Pioneering Treatment Solutions for Late-Stage Age-Related Macular Degeneration
RARITAN, NJ, December 2, 2020 – Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, today announced the acquisition of rights to Hemera Biosciences, LLC’s investigational gene therapy HMR59, administered as a one-time, outpatient, intravitreal injection to help preserve vision in patients with geographic atrophy, a late-stage and severe form of age-related macular degeneration (AMD). Financial terms of the transaction with Hemera Biosciences, a privately-owned biotechnology company, are not being disclosed. Patients with AMD often have low levels of CD59, a prote...
Source: Johnson and Johnson - December 2, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

River Blindness May Have Stopped Spreading in Most of the Americas River Blindness May Have Stopped Spreading in Most of the Americas
The spread of river blindness, or onchocerciasis, may have been halted in nearly two-thirds of the 34,000 people who remain at risk in the Americas, new evidence suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 30, 2020 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Professor works to bring new brain implant for the blind closer to reality
(University of Texas at Dallas) Researchers from The University of Texas at Dallas and partner institutions have developed an implant device that aims to generate a rough perception of sight for people with blindness. The device will be tested in a small clinical trial. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - November 23, 2020 Category: International Medicine & Public Health Source Type: news

Monitoring glaucoma at home
(City University London) Glaucoma is a chronic condition that affects cells at the back of the eye. It is the leading cause of irreversible blindness worldwide. People with glaucoma, or at risk of developing glaucoma, require lifelong monitoring, including regular eye tests to track the progression of the disease. A study from City, University of London is the first in the world that suggests glaucoma eye tests can be performed accurately at home by patients themselves. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 20, 2020 Category: International Medicine & Public Health Source Type: news

Missing the radiological forest for the trees
(University of Utah) Even experienced radiologists, when looking for one abnormality, can completely miss another. The results, published in Psychonomic Bulletin& Review, show that inattentional blindness can befall even experts. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - November 18, 2020 Category: International Medicine & Public Health Source Type: news

Late-Breaking 12-Month Data of Investigational RPGR Gene Therapy Shows Statistically Significant and Continued Vision Improvement in Patients with X-Linked Retinitis Pigmentosa
RARITAN, N.J., November 13, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new 12-month data from the ongoing Phase 1/2 trial (NCT03252847) of its investigational gene therapy for inherited retinal disease X-linked retinitis pigmentosa (XLRP). The data showed that low and intermediate doses were well-tolerated and continued to demonstrate statistically significant sustained or increased vision improvement across multiple metrics (mean sensitivity, volumetric and pointwise) and modalities (full-field static perimetry and microperimetry). Data on the novel adeno-associated virus re...
Source: Johnson and Johnson - November 13, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Nigeria: 50 Million At Risk of River Blindness - Official
[Premium Times] The official noted that "people become blind early in life as from 20-30 years." (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 10, 2020 Category: African Health Source Type: news

Nigeria: 50 Million Nigerians At Risk of Onchocerciasis - Programme Manager
[Vanguard] Mr Michael Igbe, the Programme Manager, National Onchocerciasis Elimination Programme, Federal Ministry of Health, says about 50 million Nigerians are at risk of getting infected with onchocerciasis, also called River Blindness. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 8, 2020 Category: African Health Source Type: news

A nose job without the knife? Doctors say 'liquid rhinoplasty' isn't worth the risk
"Liquid rhinoplasty" is marketed as a relatively painless and quick alternative to going under the knife. But doctors say there are serious risks — including death of the skin around the injection area or even blindness. (Source: CBC | Health)
Source: CBC | Health - October 29, 2020 Category: Consumer Health News Tags: News/Canada/British Columbia Source Type: news

New strategy for treating common retinal diseases shows promise
(Scripps Research Institute) Scientists at Scripps Research have uncovered a potential new strategy for treating eye diseases that affect millions of people around the world, often resulting in blindness. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 27, 2020 Category: International Medicine & Public Health Source Type: news

Common treatment for diabetic macular edema not effective in Black individuals
(Boston Medical Center) A medication frequently used to treat diabetic macular edema, which is the most common cause of blindness in people with diabetes, is less effective when used to treat the condition in Black patients, new study results show. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - October 22, 2020 Category: International Medicine & Public Health Source Type: news

Does Retinoblastoma Cause Blindness?
Title: Does Retinoblastoma Cause Blindness?Category: Diseases and ConditionsCreated: 10/21/2020 12:00:00 AMLast Editorial Review: 10/21/2020 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - October 21, 2020 Category: Cancer & Oncology Source Type: news

Dangerous beauty: UK moves to ban Botox, lip fillers for teens
Cosmetic treatments can put teens at risk of infection, scarring, tissue death and even blindness, advocates warn. (Source: Reuters: Health)
Source: Reuters: Health - October 18, 2020 Category: Consumer Health News Source Type: news

What Does a Person With Face Blindness See?
Title: What Does a Person With Face Blindness See?Category: Diseases and ConditionsCreated: 10/15/2020 12:00:00 AMLast Editorial Review: 10/15/2020 12:00:00 AM (Source: MedicineNet Eyesight General)
Source: MedicineNet Eyesight General - October 15, 2020 Category: Opthalmology Source Type: news

Tanzania: Conduct Regular Eye Checkup, Tanzanians Told
[Daily News] THE public has been advised to go on regular eye checkup and early treatment in case of symptoms to tame blindness and visual impairment. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 9, 2020 Category: African Health Source Type: news

What Are the Symptoms of Herpes Simplex Keratitis?
Discussion Herpes simplex virus (HSV) infections are common with an estimated 50% of the US population being infected by age 30, and with latent infection harboring in the trigeminal nerve in 100% of people by age 60 years. HSV infections can cause a vesicular or pustular skin rash that is painful, burning or pruritic and also flu-like symptoms with fever, chills, headache, and fatigue. HSV can also be asymptomatic. To laymen, herpes simplex viruses cause “cold sores,” but to health care personnel, herpes causes many systemic infections including eczema herpeticum, folliculitis, herpes gladiatorum, whitlow, e...
Source: PediatricEducation.org - October 5, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

End Ban on Cornea Donations from Gay Men: Study
A corneal transplant can cure some forms of blindness and visual impairment. The United States bans men from donating if they have had gay sex in the past five years; Canada has a 12-month restriction. (Source: WebMD Health)
Source: WebMD Health - September 29, 2020 Category: Consumer Health News Source Type: news

Rules on Cornea Donations From Gay Men Prevent Sight-Restoring Surgery: Study
TUESDAY, Sept. 29, 2020 -- U.S. and Canadian restrictions on cornea donations from gay and bisexual men prevent thousands of vision-restoring transplants and need to be changed, researchers say. A corneal transplant can cure some forms of blindness... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 29, 2020 Category: General Medicine Source Type: news

Blindness and neurological sequelae following carbon monoxide poisoning: effective treatment with hyperbaric oxygen - Cardoso PC, La Fuente A, Subbotina N, Cargnel EG.
We present two patients who developed visual deterioration due to carbon monoxide poisoning. They were treated with hyperbaric oxygen and recovered not only their vision but also they improved neurological signs and symptoms. We believe that implementation... (Source: SafetyLit)
Source: SafetyLit - September 16, 2020 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

New data show Roche ’s ENSPRYNG (satralizumab) significantly reduces severity and risk of relapse in neuromyelitis optica spectrum disorder (NMOSD)
Basel, 10 September 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) will present new ENSPRYNG ® (satralizumab) data on reducing relapse severity in the treatment of neuromyelitis optica spectrum disorder (NMOSD), a rare disease of the central nervous system. These data are being presented at MSVirtual2020, the 8th joint ACTRIMS-ECTRIMS meeting, in addition to longer-term efficacy data supporting the continued effect of ENSPRYNG on reducing the risk of NMOSD relapse, as well as its favourable benefit:risk profile.“The data for ENSPRYNG at MSVirtual2020 are promising and suggest it significantly reduces relapse severity ...
Source: Roche Investor Update - September 10, 2020 Category: Pharmaceuticals Source Type: news

New data show Roche ’s ENSPRYNG (satralizumab) significantly reduces severity and risk of relapse in neuromyelitis optica spectrum disorder (NMOSD)
Basel, 10 September 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) will present new ENSPRYNG ® (satralizumab) data on reducing relapse severity in the treatment of neuromyelitis optica spectrum disorder (NMOSD), a rare disease of the central nervous system. These data are being presented at MSVirtual2020, the 8th joint ACTRIMS-ECTRIMS meeting, in addition to longer-term efficacy data supporting the continued effect of ENSPRYNG on reducing the risk of NMOSD relapse, as well as its favourable benefit:risk profile.“The data for ENSPRYNG at MSVirtual2020 are promising and suggest it significantly reduces relapse severity ...
Source: Roche Media News - September 10, 2020 Category: Pharmaceuticals Source Type: news

Case report: projectile into right frontal lobe from a nail gun - Patchana T, Taka TM, Ghanchi H, Wiginton J, Wacker M.
We present a case of a nail gun injury penetrating the right maxillary sinus and frontal lobe with complaints of headache and right eye blindness. After surgical removal and treatment, there were no neurological deficits aside from the persistence of right... (Source: SafetyLit)
Source: SafetyLit - September 5, 2020 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

My face blindness is embarrassing – but it tells me a lot about other people
I grew up thinking I just didn ’t fit it. Now, I immediately tell people I can’t recognise faces – and their response is a good measure of kindness versus egoSunday morning. I walk down to the beach with the dog straining at her lead. I ’m already on high alert. It’s the moment in the week when people are most likely to be wandering along the seafront, feeling chatty. I’m mentally priming myself, sorting through the categories I might encounter: parents from the schoolyard (hopefully with their children), people I’ve worked with (increasingly hopeless), neighbours from the surround...
Source: Guardian Unlimited Science - August 30, 2020 Category: Science Authors: Katherine May Tags: Life and style Psychology Science Health & wellbeing Source Type: news

IrisVision and Seva Foundation work to treat vision impairment; Iron Bow Technologies integrates with ViiMed; and more digital health deals
In a partnership announced this week, IrisVision and Seva Foundation plan to develop new technology to treat vision impairment and prevent blindness in underserved regions of the globe. Seva has agreed to provide IrisVision with a $200,000 grant to create the technology. (Source: mobihealthnews)
Source: mobihealthnews - August 27, 2020 Category: Information Technology Source Type: news

Causes of childhood blindness and visual impairment in Ouagadougou: About 398 cases - Ahnoux-Zabsonre A, Meda R, Diallo JW, Djiguimde WP, Sanou J, Meda-Hien G, Sankara P, Diomand é A.
INTRODUCTION: Childhood blindness is a public health problem in developing countries. The goal of this study was to focus on the epidemiological and clinical patterns of moderate to severe, uni- or bilateral childhood blindness and severe visual impairment... (Source: SafetyLit)
Source: SafetyLit - August 26, 2020 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Remodeling vasculature to avoid blindness
(Source: ScienceNOW)
Source: ScienceNOW - August 19, 2020 Category: Science Authors: Podrez, E. A., Byzova, T. V. Tags: Medicine, Diseases perspective Source Type: news

Neutrophil extracellular traps target senescent vasculature for tissue remodeling in retinopathy
In developed countries, the leading causes of blindness such as diabetic retinopathy are characterized by disorganized vasculature that can become fibrotic. Although many such pathological vessels often naturally regress and spare sight-threatening complications, the underlying mechanisms remain unknown. Here, we used orthogonal approaches in human patients with proliferative diabetic retinopathy and a mouse model of ischemic retinopathies to identify an unconventional role for neutrophils in vascular remodeling during late-stage sterile inflammation. Senescent vasculature released a secretome that attracted neutrophils an...
Source: ScienceNOW - August 19, 2020 Category: Science Authors: Binet, F., Cagnone, G., Crespo-Garcia, S., Hata, M., Neault, M., Dejda, A., Wilson, A. M., Buscarlet, M., Mawambo, G. T., Howard, J. P., Diaz-Marin, R., Parinot, C., Guber, V., Pilon, F., Juneau, R., Laflamme, R., Sawchyn, C., Boulay, K., Leclerc, S., Abu Tags: Cell Biology, Medicine, Diseases, Online Only r-articles Source Type: news

Ocular injuries and blindness caused by crowd control measures in civil protests - Lum C, Schallhorn J, Lum F, Ramanathan S, Oatts J, de Alba Campomanes AG, Seitzman G.
Thirty cases of ocular injuries during civil protests were identified, with 27% suffering a ruptured globe, 23% with an orbital fracture, 20% with a resultant macular hole, and 33% with permanent blindness in the involved eye. Language: en... (Source: SafetyLit)
Source: SafetyLit - August 15, 2020 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Former Johnson & Johnson exec joins CorneaGen board
CorneaGen announced Thursday that Tom Frinzi, formerly worldwide president of Johnson& Johnson Vision, joined its board of directors. Seattle-based CorneaGen focuses on developing technologies to cure corneal blindness by 2040 and provides donor tissues for cornea transplants. Frinzi, with more than 35 years of experience in ophthalmology, will lead CorneaGen’s board as executive chair, replacing William Link, who will remai n on the board. “Tom’s deep experience in bringing ophthalmology… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 13, 2020 Category: Pharmaceuticals Authors: Megan Campbell Source Type: news

Heavy class A drug use linked to heightened risk of sight loss in US military
(BMJ) Heavy use of class A drugs, such as heroin, methamphetamine, or cocaine is linked to a heightened risk of partial or total blindness among US military personnel, finds research published online in the journal BMJ Military Health. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - August 13, 2020 Category: International Medicine & Public Health Source Type: news

Blindness breakthrough as monthly jabs first to half leading cause of sight loss
MONTHLY jabs of protein can halt the progression of a leading cause of sight loss, scientists have revealed. (Source: Daily Express - Health)
Source: Daily Express - Health - August 2, 2020 Category: Consumer Health News Source Type: news

FDA Broadens Alert on Methanol Hand Sanitizers
Deaths, blindness tied to toxic ingredient found in these sanitizers ... En espa ñol | The U.S. Food and Drug Administration (FDA) is warning consumers to stop using 94 hand sanitizer products from ... (Source: AARP.org News)
Source: AARP.org News - August 2, 2020 Category: American Health Source Type: news

Researchers discover stem cells in optic nerve that preserve vision
(University of Maryland School of Medicine) Researchers at the University of Maryland School of Medicine (UMSOM) have for the first time identified stem cells in the region of the optic nerve, which transmits signals from the eye to the brain. The finding, published this week in the journal Proceedings of the National Academy of Sciences (PNAS), presents a new theory on why the most common form of glaucoma may develop and provides potential to treat a leading cause of blindness. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 30, 2020 Category: International Medicine & Public Health Source Type: news